Life Sciences Financings and Commentary #8

Axial
5 min readMay 22, 2020

Get these analyses to your inbox — https://axialfc.substack.com/ This is a newsletter for new financing events with some simple analysis. More well thought out work can be found at — https://axial.substack.com/

Axial invests and partners in early-stage life sciences companies. If you or someone you know has a great idea or company in life sciences, Axial would be excited to get to know you and possibly invest in your vision and company — info@axialsprawl.com

Life Sciences Financings and Commentary #8 — May 16, 2020 — May 22, 2020

Financings

Number of deals: 28 & Total capital invested: $1.29B

- Amplyx Pharma raised $53M from Sofinnova, Pfizer, and Adage Capital to develop new medicines for fungal infections — https://www.fiercebiotech.com/biotech/pfizer-adage-bump-up-amplyx-s-series-c-to-top-90-million

- Amwell raised $194M from Allianz and Takeda to scale up their telehealth product.

- Apollo Agriculture raised $6M led by Anthemis Exponential Ventures to build a farm management software product to help growers manage their farms and finance them.

- ARTMS raised $19M led by Deerfield to grow their diagnostic imaging isotope business.

--

--